Records containing: Hepatitis C, Chronic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-08-06Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-08-04Efficacy and Safety of PEG-Intron Plus Rebetol in Subjects With Chronic Hepatitis C Genotype 1 Non Responder to Pegasys
-
CLINICAL_TRIALS study record update · 2009-07-23Phase IV Study of Tailored Therapy With Peg Interferon Alfa 2b and Ribavirin for Patients With Genotype 3 and High Viral Load. Genotype 3 Extended Treatment for HCV (GET-C Study)
-
CLINICAL_TRIALS study record update · 2009-07-17Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Slovenia
-
CLINICAL_TRIALS study record update · 2009-07-08A Study to Assess Treatment With PEG-Intron® and Rebetol® in Naïve Patients With Genotype 1 Chronic Hepatitis C and Slow Virological Response
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-06-02Evaluation of Adherence Rate in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-06-02Evaluation of Satisfaction in Patients Receiving PegIntron Pen / Rebetol for Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-03-09Assessment of the Safety, Efficacy, Tolerability and Pharmacokinetics of PEG-Intron® Plus REBETOL® in Pediatric Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2009-02-16Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung
-
CLINICAL_TRIALS study record update · 2009-02-04Long-Term Evaluation Follow-up of Neurocognitive Performance and Emotional State in Patients With Chronic Hepatitis C Infection and a Former (Peg)Interferon Alfa-2b-Based Therapy
-
CLINICAL_TRIALS study record update · 2008-12-11PEG-Intron Plus REBETOL for the Treatment of Subjects With Chronic Hepatitis C Who Failed to Respond to Previous Combination Therapy (Any Alpha Interferon Treatment in Combination With Ribavirin)
-
CLINICAL_TRIALS study record update · 2008-07-29Open Multicenter Study of Combination Therapy With Weight-Based PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1. Impact of the Combination Therapy on Sustained Virological Response and Tolerability, in These Patients.
-
CLINICAL_TRIALS study record update · 2008-02-08Randomized Double Blind Trial Comparing the Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin for Initial Treatment of Patients With Hepatitis C With Genotype 1 or 4 and Severe Fibrosis
-
CLINICAL_TRIALS study record update · 2008-01-21A Phase II, Multi-Center, Extension Study to Evaluate the Safety and Efficacy of Celgosivir in Combination With Peginterferon Alfa-2b, With or Without Ribavirin, for an Additional 36 Weeks
-
CLINICAL_TRIALS study record update · 2008-01-15ClinicalTrials.gov study NCT00039962
-
CLINICAL_TRIALS study record update · 2008-01-15ClinicalTrials.gov study NCT00040027
-
CLINICAL_TRIALS study record update · 2007-08-30Pilot Study on Interferon Gamma in Association With Peg-Interferon Alpha 2a and Ribavirin Among Patients With a Chronic Hepatitis C and Non Responders to the Association of Peg-Interferon Alpha 2b or 2a and Ribavirin ANRS HC16 Gammatri
-
CLINICAL_TRIALS study record update · 2007-08-13An Open Label, Comparative, Multi-Center Study, to Evaluate the Efficacy and Safety of Peginterferon Alfa-2a Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2007-06-13Efficacy and Safety of Peginterferon alfa2a and Ribavirin for the Second Line Treatment of Chronic Hepatitis C in HIV Infected Patients Previously Non Responders to a First Anti-HCV Treatment
-
CLINICAL_TRIALS study record update · 2007-06-13Randomized Placebo-Controlled Trial of a Triple Therapy Combining Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine Versus Peginterferon Alfa-2a Plus Ribavirin Plus Placebo in Hepatitis C-Infected Patients Non Responders to a First-Line Therapy of Interferon and Ribavirin
-
CLINICAL_TRIALS study record update · 2007-03-09Randomized, Open-Label, Multicenter Study Examining the Effects of Duration of Treatment of PEGASYS® in Combination With Daily COPEGUS® + Amantadine in Patients With Chronic HCV After Relapse to Previous (Peg)IFN + Ribavirin Therapy.
-
CLINICAL_TRIALS study record update · 2007-01-12Efficacy and Safety of the Association With Pentoxyphilline and Tocopherol on the Fibrosis in Patients With Chronic Hepatitis C
-
CLINICAL_TRIALS study record update · 2006-09-29A Phase II, Randomized, Active-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Celgosivir in Combination With Peginterferon Alfa-2b, With and Without Ribavirin, for 12 Weeks in Patients With Chronic Hepatitis C Infection (Genotype 1) Who Failed to Respond to Pegylated α Interferon-Based Therapy
-
CLINICAL_TRIALS study record update · 2006-08-18IdB 1016 in Hepatitis C
-
CLINICAL_TRIALS study record update · 2006-08-18Evaluating Silymarin for Chronic Hepatitis C